09.23.25 -- Gedatolisib Shatters Phase 3 Goals And Scales For Breast Cancer Breakthrough

Discover how agentic AI is poised to transform Enterprise Asset Management in regulated industries to enhance compliance, reduce downtime, and bridge fragmented systems for resilient operations.

Early planning for scale-up and biologics license application activities can maximize your chances of success by allowing sufficient time to develop launch options and prevent costly delays and setbacks.

Review a procedure in which compendial testing is complemented by a simultaneous rapid test that uses an identical sample to generate much earlier results while allowing the compendial test to continue.

Learn about smart manufacturing and how connected, electronic batch records enable smarter and more efficient manufacturing capable of addressing current and future production challenges.

As molecular complexity continues to increase, flow chemistry is becoming an essential enabling technology to facilitate the integration of complex synthetic methods into API production.

AI-driven multiplexed imaging reveals neuroimmune interactions in Alzheimer’s disease, identifying immune cell subtypes near pathological hallmarks like Β-amyloid plaques offering therapeutic insights.

Here, we provide systematic methods to increase return on investment. Examine the seven primary investment recovery channels.

Explore the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.

Life sciences manufacturers face growing pressure to adopt AI while staying compliant. Uncover five key areas to evaluate AI tools and how to simplify adoption with regulatory assurance.

Reconstructed nasal epithelium and CT-based 3D nasal casts provide more predictive, physiologically relevant models for assessing nasal drug delivery, improving accuracy in formulation development.

AI-powered predictive maintenance with wireless vibration sensors prevented costly batch loss and production shutdowns in manufacturing by detecting and fixing equipment issues before failure.

Challenges specific to eye physiology complicate the development of new therapies and necessitate innovative delivery methods. Biodegradable polymers show promise in addressing these challenges.

As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to see how expedited timelines can be achieved.

Gain insight into the benefits of flexible pilot plant equipment. Seamlessly scale up your processes, optimize your formulations, and save costs with in-house small-volume production.

Discover several important factors needed to effectively support oral solid dosage therapeutic manufacturing and overcome the complexities involved.

GMP compliance requires monitoring microbial contamination levels in cleanrooms and clean spaces. It is important to know the role active air samplers play in this process and parameters for evaluating them.